Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have unveiled a pioneering study shedding light on the intricate mechanisms underlying Alzheimer’s disease (AD). The study, titled “Effects of amyloid-β-mimicking peptide hydrogel matrix on neuronal progenitor cell phenotype,” represents a significant leap forward in understanding the interplay between amyloid-like structures and neuronal cells.
Atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights | Psychedelic Invest
Phase 2b study of RL-007 in CIAS patients continues to be on track to report data in 2H 2024 and data from the EMP-01 (MDMA
November 14, 2023